日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer

埃拉塞群在ER+、HER2-、ESR1突变型转移性乳腺癌中的真实世界疗效

Rugo, Hope S; Kaklamani, Virginia; McArthur, Heather; Wander, Seth A; Gradishar, William; Mahtani, Reshma; Pegram, Mark; Lustberg, Maryam; Swallow, Elyse; Maitland, Jessica; Kloss, Sebastian; Wasserman, Tomer; Tolaney, Sara M

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer

III期炎性乳腺癌和非炎性乳腺癌的生存和治疗模式

Leone, José P; Leone, Julieta; De Placido, Pietro; Nakhlis, Faina; Schlam, Ilana; Hirko, Kelly A; Hazra, Aditi; Troll, Elizabeth; Bellon, Jennifer R; Vallejo, Carlos T; Lin, Nancy U; Tolaney, Sara M; Lynce, Filipa

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6

细胞周期蛋白D-CDK4/6对免疫CD155-CD226-TIGIT轴的调控

Fassl, Anne; Palacios Espinoza, Miriam; Butter, Deborah; Kolodziejczyk, Aleksandra; Seehawer, Marco; Hill, Charlotte; Ning, Xiaohan; Branigan, Timothy B; Peñailillo, Johany; Saengboonmee, Charupong; Jadhav, Heta; Charbonnier, Louis-Marie; Waks, Adrienne G; Strawser, Corinne; McDonnell, Donald P; Shapiro, Geoffrey I; Tolaney, Sara M; Polyak, Kornelia; Sammons, Sarah; Wucherpfennig, Kai W; Sicinski, Piotr

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia

Sacituzumab govitecan治疗转移性乳腺癌患者:来自北美、欧洲和亚洲患者的汇总安全性分析

Rugo, H S; Tolaney, S M; Cortés, J; Marmé, F; de Azambuja, E; Xu, B; Sohn, J; Naito, Y; Valdez, T; Gary, D; Zhu, J; Lai, C; Bardia, A

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer

新辅助帕博利珠单抗联合化疗治疗非转移性三阴性炎性乳腺癌,达到病理完全缓解

Lynce, F; Valenza, C; Niman, S M; Bertucci, F; Kai, M; Ryan, S; Troll, E; Layman, R M; Fanucci, K A; Giordano, A; Nasrazadani, A; Nakhlis, F; Bellon, J; Warren, L; Block, C; Schumer, S; Lucci, A; Krishnamurthy, S; Trapani, D; Lerebours, F; Dalenc, F; Levy, C; Petit, T; Leheurteur, M; Bachelot, T; Tredan, O; Ribeiro, J M; Pistilli, B; Zagami, P; Ladoire, S; Lopez Almeida, L; Zemmour, C; Carey, L A; Tolaney, S M; Valero, V; Curigliano, G; Regan, M M; Goncalves, A; Woodward, W A

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data

探讨淋巴结阳性、高危、激素受体阳性、HER2阴性早期乳腺癌患者的治疗差距和预后风险:真实世界数据分析

Tolaney, S M; Sammons, S; Sandoval-Leon, A; Cortes, J; Liepa, A M; Grimes, B R; He, D; Cui, Z L; Roose, J; Gathirua-Mwangi, W; Moreira, K; O'Shaughnessy, J; Neven, P; Johnston, S R D; Rugo, H S

Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancer

循环肿瘤DNA在早期乳腺癌新辅助内分泌治疗中的应用

Grinshpun, A; Dustin, D; Cai, M; Hughes, M; DiLullo, M; Moore, M; Yardley, D; Mayer, I A; Symmans, W F; Mayer, E L; Winer, E P; Lin, N U; Tolaney, S M; Metzger, O; Jeselsohn, R

Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials

在ER阳性、HER2阴性晚期乳腺癌中,伊姆鲁司群联合阿贝西利与氟维司群联合阿贝西利的疗效比较:三项III期试验的间接治疗比较

Jhaveri, K; Bidard, F C; Kalinsky, K; Neven, P; Rugo, H S; Tolaney, S M; Litchfield, L M; von Laue, C C; Traore, S; Sapunar, F; Li, Y; O'Shaughnessy, J

Genomic landscape, immune microenvironment and survival in male versus female breast cancer

基因组图谱、免疫微环境与男性和女性乳腺癌患者的生存率

Trapani, D; Deshmukh, S K; Samec, T; Wu, S; Xiu, J; Walker, P; Abravanel, D L; Advani, P; Spanheimer, P M; Lin, N U; Curigliano, G; Graff, S L; Lustberg, M; Sledge, G W; Tolaney, S M; Leone, J P

Tumor genomics in patients younger than 40 years of age with metastatic breast cancer

40岁以下转移性乳腺癌患者的肿瘤基因组学

Brantley, Kristen D; Kodali, Ananya; Kirkner, Gregory J; Hughes, Melissa E; Li, Yvonne; Files, Janet; Strauss, Sarah; Feeney, Anne-Marie; Mohammed-Abreu, Ayesha; Sousa, Romualdo Barroso; Bychkovsky, Brittany; Tannenbaum, Charlotte; Loucks, Maggie; LeStage, Barbara K; King, Tari; Johnson, Bruce E; Sholl, Lynette; Dillon, Deborah; Tolaney, Sara M; Cherniack, Andrew D; Partridge, Ann H; Lin, Nancy U; Garrido-Castro, Ana C